Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
Recruiting · NCT03710902 · Interventional (participants receive a specific treatment) · Lead sponsor: Jukka Putaala
View the official record on ClinicalTrials.gov →Interventions studied
ECG monitoring for 3 weeksSelf-monitoring of BP and self-titration of antihypertensive medication
What this trial is about
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
Who can take part
Age range
40 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
- Age ≥40 years
- Pre-existing or newly diagnosed hypertension
- Informed consent from the patient or legal representative
Exclusion criteria
- Known high-risk source of cardioembolism
- Known indication for anticoagulation
- Contraindication for anticoagulation
- Pacemaker
- Non-compliance to study interventions as judged by the investigator
- Serious condition hampering the study conduct
Where it is running
4 locations listed.
- Helsinki University Hospital - Helsinki, Finland
- Hyvinkää Hospital - Hyvinkää, Finland
- Kanta-Häme Central Hospital - Hämeenlinna, Finland
- Päijät-Häme Central Hospital - Lahti, Finland